A lipase catalysed enantioselective hydrolysis process under in situ racemization of the remaining (R)-ibuprofen ester substrate with sodium hydroxide as the catalyst was developed for the production of S-ibuprofen from (R,S)-ibuprofen ester in isooctane. Detailed investigations on parameters study indicated that 0.5 M NaOH, addition of 20% (v/v) co-solvent (dimethyl sulphoxide), operating temperature of 45 degrees C, and 40 mmol/L substrate gave 86% conversion and 99.4% optical purity of S-ibuprofen in dynamic kinetic resolution. Meanwhile, in common enzymatic kinetic resolution process, only 42% conversion of the racemate and 93% enantiomeric excess of the product was obtained which are of lower values as compared to dynamic kinetic resolution. The S-ibuprofen produced during each process was evaluated and approximately 50% increment in concentration of S-acid product was produced when dynamic kinetic resolution was applied into the process.
The effects of initial concentration of lead, temperature, biomass loading and pH were investigated for an optimized condition of lead uptake from the aqueous solution. The optimization process was analyzed using Central Composite Face-Centered Experimental Design in Response Surface Methodology (RSM) by Design Expert Version 5.0.7 (StatEase, USA). The design was employed to derive a statistical model for the effect of parameters studied on the removal of lead ion from aqueous solution. The coefficient of determination, R2 was found to be 92.36%. The initial concentration of 50.0 mg/L, temperature of 60 degrees C, biomass loading of 0.2 g and pH of 5.0 had been found to be the optimum conditions for the maximum uptake of lead ions in 98.11% batch mode. Under the optimum conditions, the lead uptake was attained to be circa 8.60 mg/g.